• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶在肾脏稳态和疾病中的作用:最新研究进展。

Matrix metalloproteinases in kidney homeostasis and diseases: an update.

机构信息

Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.

VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States.

出版信息

Am J Physiol Renal Physiol. 2024 Dec 1;327(6):F967-F984. doi: 10.1152/ajprenal.00179.2024. Epub 2024 Oct 3.

DOI:10.1152/ajprenal.00179.2024
PMID:39361724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11687849/
Abstract

Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases with important roles in kidney homeostasis and pathology. While capable of collectively degrading each component of the extracellular matrix, MMPs also degrade nonmatrix substrates to regulate inflammation, epithelial plasticity, proliferation, apoptosis, and angiogenesis. More recently, intriguing mechanisms that directly alter podocyte biology have been described. There is now irrefutable evidence for MMP dysregulation in many types of kidney disease including acute kidney injury, diabetic and hypertensive nephropathy, polycystic kidney disease, and Alport syndrome. This updated review will detail the complex biology of MMPs in kidney disease.

摘要

基质金属蛋白酶(MMPs)是锌依赖性内肽酶,在肾脏内稳态和病理中发挥重要作用。MMPs 能够集体降解细胞外基质的每一种成分,也能降解非基质底物,以调节炎症、上皮可塑性、增殖、凋亡和血管生成。最近,人们描述了一些令人感兴趣的直接改变足细胞生物学的机制。目前,有不可辩驳的证据表明,许多类型的肾脏疾病(包括急性肾损伤、糖尿病和高血压性肾病、多囊肾病和 Alport 综合征)中 MMP 失调。本综述将详细介绍 MMP 在肾脏疾病中的复杂生物学。

相似文献

1
Matrix metalloproteinases in kidney homeostasis and diseases: an update.基质金属蛋白酶在肾脏稳态和疾病中的作用:最新研究进展。
Am J Physiol Renal Physiol. 2024 Dec 1;327(6):F967-F984. doi: 10.1152/ajprenal.00179.2024. Epub 2024 Oct 3.
2
Matrix metalloproteinases in kidney homeostasis and diseases.基质金属蛋白酶在肾脏稳态和疾病中的作用。
Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1351-61. doi: 10.1152/ajprenal.00037.2012. Epub 2012 Apr 4.
3
Kidney Fibrosis and Matrix Metalloproteinases (MMPs).肾纤维化与基质金属蛋白酶(MMPs)
Front Biosci (Landmark Ed). 2024 May 16;29(5):192. doi: 10.31083/j.fbl2905192.
4
Role of matrix metalloproteinases in renal pathophysiologies.基质金属蛋白酶在肾脏病理生理学中的作用。
Am J Physiol Renal Physiol. 2007 Mar;292(3):F905-11. doi: 10.1152/ajprenal.00421.2006. Epub 2006 Dec 26.
5
Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.基质金属蛋白酶在退行性肾脏疾病中的作用。
Curr Med Chem. 2018;25(15):1805-1816. doi: 10.2174/0929867325666171205143441.
6
Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target.基质金属蛋白酶在肾脏疾病中的作用:在发病机制中的角色及作为治疗靶点的潜力
Prog Mol Biol Transl Sci. 2017;148:31-65. doi: 10.1016/bs.pmbts.2017.03.001. Epub 2017 May 4.
7
Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.基质金属蛋白酶和基质金属蛋白酶组织抑制剂与肾脏疾病。
Adv Clin Chem. 2021;105:141-212. doi: 10.1016/bs.acc.2021.02.003. Epub 2021 Mar 9.
8
Matrix Metalloproteinases in Non-Neoplastic Disorders.非肿瘤性疾病中的基质金属蛋白酶
Int J Mol Sci. 2016 Jul 21;17(7):1178. doi: 10.3390/ijms17071178.
9
Changes in matrix metalloproteinases and their inhibitors in kidney transplant recipients.肾移植受者体内基质金属蛋白酶及其抑制剂的变化
Exp Clin Transplant. 2012 Aug;10(4):332-43. doi: 10.6002/ect.2012.0013.
10
Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis.人类基质金属蛋白酶:改变系膜内环境稳定的特征及病理作用
Microsc Res Tech. 2008 May;71(5):371-9. doi: 10.1002/jemt.20565.

引用本文的文献

1
Insight into blood proteinase-inhibitor system and pathogenesis of renal tuberculosis induced by phylogenomically different Mycobacterium tuberculosis strains in rabbit model.兔模型中不同系统发育的结核分枝杆菌菌株诱导肾结核的血液蛋白酶-抑制剂系统及发病机制研究
BMC Nephrol. 2025 Aug 20;26(1):473. doi: 10.1186/s12882-025-04411-w.
2
The Life of a Kidney Podocyte.肾足细胞的生命历程。
Acta Physiol (Oxf). 2025 Aug;241(8):e70081. doi: 10.1111/apha.70081.
3
Proteomic analysis of human kidney biopsies unveils emerging acute kidney injury very early after liver graft reperfusion.

本文引用的文献

1
Urine MMP7 as a kidney injury biomarker.尿基质金属蛋白酶7作为一种肾损伤生物标志物。
Clin Kidney J. 2023 Sep 14;17(1):sfad233. doi: 10.1093/ckj/sfad233. eCollection 2024 Jan.
2
Urinary matrix metalloproteinase-7 is a sensitive biomarker to evaluate renal tubular injury in patients with minimal change disease and focal segmental glomerulosclerosis.尿基质金属蛋白酶-7是评估微小病变病和局灶节段性肾小球硬化症患者肾小管损伤的敏感生物标志物。
Clin Kidney J. 2023 Feb 10;17(1):sfad027. doi: 10.1093/ckj/sfad027. eCollection 2024 Jan.
3
The association between activation of the ERK1/2-NF-κB signaling pathway by TIMP2 expression and chronic renal allograft dysfunction in the CRAD rat model.
对人类肾活检组织进行蛋白质组学分析发现,肝移植再灌注后极早期就出现了新发急性肾损伤。
J Transl Med. 2025 Jun 16;23(1):658. doi: 10.1186/s12967-025-06695-w.
4
Transcriptomic Approach in Understanding Fabry Nephropathy: A Review of the Literature and Proof-of-Concept.转录组学方法在理解法布里肾病中的应用:文献综述与概念验证
Genes (Basel). 2025 May 19;16(5):601. doi: 10.3390/genes16050601.
5
Diffusion Tensor Imaging Magnetic Resonance Imaging Assessment in a Clinical Trial of Autologous Dendritic Cell Transfer for Diabetic Kidney Disease: A Molecular Approach.糖尿病肾病自体树突状细胞移植临床试验中的扩散张量成像磁共振成像评估:一种分子方法
Diseases. 2025 May 19;13(5):159. doi: 10.3390/diseases13050159.
6
Matrix metalloproteinase-10 promotes kidney fibrosis by transactivating β-catenin signaling.基质金属蛋白酶-10通过反式激活β-连环蛋白信号通路促进肾纤维化。
Cell Death Discov. 2025 May 17;11(1):241. doi: 10.1038/s41420-025-02521-w.
7
Matrix Metalloproteinases in Ureteropelvic Junction Obstruction: Their Role in Pathogenesis and Their Use as Clinical Markers.输尿管肾盂连接处梗阻中的基质金属蛋白酶:它们在发病机制中的作用及其作为临床标志物的应用
Cells. 2025 Mar 31;14(7):520. doi: 10.3390/cells14070520.
8
Urine Matrix Metalloproteinase-7 (MMP-7) Versus Urine Albumin-to-Creatinine Ratio (ACR) as Predictors of Renal Dysfunction: A Decision Curve Analysis.尿基质金属蛋白酶-7(MMP-7)与尿白蛋白肌酐比值(ACR)作为肾功能障碍预测指标的决策曲线分析
Cureus. 2025 Jan 31;17(1):e78275. doi: 10.7759/cureus.78275. eCollection 2025 Jan.
TIMP2 表达激活 ERK1/2-NF-κB 信号通路与 CRAD 大鼠模型慢性移植肾失功的关系。
Transpl Immunol. 2024 Feb;82:101984. doi: 10.1016/j.trim.2023.101984. Epub 2024 Jan 4.
4
Matrix Metalloproteinase-7 in Urinary Extracellular Vesicles Identifies Rapid Disease Progression in Autosomal Dominant Polycystic Kidney Disease.尿细胞外囊泡中基质金属蛋白酶-7可识别常染色体显性遗传多囊肾病的快速疾病进展。
J Am Soc Nephrol. 2024 Mar 1;35(3):321-334. doi: 10.1681/ASN.0000000000000277. Epub 2023 Dec 11.
5
Cleavage of periostin by MMP9 protects mice from kidney cystic disease.MMP9 对骨桥蛋白的裂解可保护小鼠免受肾囊肿疾病的影响。
PLoS One. 2023 Dec 1;18(12):e0294922. doi: 10.1371/journal.pone.0294922. eCollection 2023.
6
Structure-Based Optimization and Biological Evaluation of Potent and Selective MMP-7 Inhibitors for Kidney Fibrosis.基于结构的优化和对具有强效和选择性的 MMP-7 抑制剂的生物学评估用于肾脏纤维化。
J Med Chem. 2023 Nov 9;66(21):14653-14668. doi: 10.1021/acs.jmedchem.3c01166. Epub 2023 Oct 20.
7
COL4A3 Mutation Induced Podocyte Apoptosis by Dysregulation of NADPH Oxidase 4 and MMP-2.COL4A3突变通过NADPH氧化酶4和MMP-2的失调诱导足细胞凋亡。
Kidney Int Rep. 2023 Jun 19;8(9):1864-1874. doi: 10.1016/j.ekir.2023.06.007. eCollection 2023 Sep.
8
TIMP-2 and IGFBP7 in human kidney biopsies in renal disease.肾病患者肾活检中的组织金属蛋白酶抑制因子2和胰岛素样生长因子结合蛋白7
Clin Kidney J. 2023 Jan 16;16(9):1434-1446. doi: 10.1093/ckj/sfad010. eCollection 2023 Sep.
9
Knockout of Matrix Metalloproteinase 2 Opposes Hypertension- and Diabetes-induced Nephropathy.基质金属蛋白酶 2 的敲除可拮抗高血压和糖尿病引起的肾病。
J Cardiovasc Pharmacol. 2023 Dec 1;82(6):445-457. doi: 10.1097/FJC.0000000000001473.
10
Matrix metalloproteinase-9 regulates afferent arteriolar remodeling and function in hypertension-induced kidney disease.基质金属蛋白酶-9 调节高血压诱导的肾脏疾病中的入球小动脉重塑和功能。
Kidney Int. 2023 Oct;104(4):740-753. doi: 10.1016/j.kint.2023.06.031. Epub 2023 Jul 7.